应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ANIK 阿尼卡医疗
交易中 05-05 10:06:50 EDT
14.77
+0.22
+1.51%
最高
14.78
最低
14.57
成交量
1.00万
今开
14.57
昨收
14.55
日振幅
1.44%
总市值
1.97亿
流通市值
1.69亿
总股本
1,331万
成交额
14.68万
换手率
0.09%
流通股本
1,144万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
TELA Bio董事会高层变动:主席道格·埃文斯及三名董事库尔特·阿扎巴津、文斯·伯吉斯、费德里卡·奥布莱恩将离任
美股速递 · 05-01
TELA Bio董事会高层变动:主席道格·埃文斯及三名董事库尔特·阿扎巴津、文斯·伯吉斯、费德里卡·奥布莱恩将离任
TELA Bio宣布董事会战略革新:引入四位资深商业领袖加速增长并推动盈利进程,同时公布2026年第一季度初步营收数据
美股速递 · 05-01
TELA Bio宣布董事会战略革新:引入四位资深商业领袖加速增长并推动盈利进程,同时公布2026年第一季度初步营收数据
阿尼卡医疗:Cingal与Hyalofast仍为2026年核心战略重点 积极筹备未来美国市场上市
美股速递 · 02-26
阿尼卡医疗:Cingal与Hyalofast仍为2026年核心战略重点 积极筹备未来美国市场上市
阿尼卡疗法盘中异动 下午盘大幅拉升5.20%
市场透视 · 02-03
阿尼卡疗法盘中异动 下午盘大幅拉升5.20%
阿尼卡医疗第三季度收入为2781.7万美元
投资观察 · 2025-11-20
阿尼卡医疗第三季度收入为2781.7万美元
阿尼卡疗法盘中异动 早盘大幅拉升5.78%报17.00美元
市场透视 · 2025-01-21
阿尼卡疗法盘中异动 早盘大幅拉升5.78%报17.00美元
阿尼卡疗法盘中异动 股价大涨6.33%报17.22美元
市场透视 · 2025-01-17
阿尼卡疗法盘中异动 股价大涨6.33%报17.22美元
阿尼卡疗法2024财年第三财季实现净利润-29.92百万美元,同比减少354.71%
市场透视 · 2024-11-10
阿尼卡疗法2024财年第三财季实现净利润-29.92百万美元,同比减少354.71%
阿尼卡疗法盘中异动 股价大涨5.28%报17.16美元
市场透视 · 2024-11-07
阿尼卡疗法盘中异动 股价大涨5.28%报17.16美元
阿尼卡疗法盘中异动 股价大涨5.14%
市场透视 · 2024-11-05
阿尼卡疗法盘中异动 股价大涨5.14%
阿尼卡疗法盘中异动 股价大跌13.37%
市场透视 · 2024-10-31
阿尼卡疗法盘中异动 股价大跌13.37%
公司概况
公司名称:
阿尼卡医疗
所属市场:
NASDAQ
上市日期:
--
主营业务:
Anika Therapeutics, Inc.成立于1992年。该公司是骨关节炎疼痛管理和再生解决方案领域的全球领导者,专注于早期骨科干预。公司利用其专有的透明质酸(“HA”)技术开发差异化产品。在与医生建立牢固合作关系的推动下,Anika致力于开拓基于HA的创新技术,重新定义骨科护理。
发行价格:
--
{"stockData":{"symbol":"ANIK","market":"US","secType":"STK","nameCN":"阿尼卡医疗","latestPrice":14.77,"timestamp":1777989966519,"preClose":14.55,"halted":0,"volume":10013,"delay":0,"changeRate":0.015120274914089267,"floatShares":11438699,"shares":13305624,"eps":-0.781975,"marketStatus":"交易中","change":0.22,"latestTime":"05-05 10:06:50 EDT","open":14.57,"high":14.78,"low":14.57,"amount":146823.853199,"amplitude":0.014433,"askPrice":14.87,"askSize":222,"bidPrice":14.68,"bidSize":4,"shortable":3,"etf":0,"ttmEps":-0.781975,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1778011200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":14.55,"postHourTrading":{"tag":"盘后","latestPrice":14.55,"preClose":14.55,"latestTime":"16:10 EDT","volume":394,"amount":5732.7,"timestamp":1777925404677,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.499733,"impliedVol":0.4869,"impliedVolPercentile":0.5378},"requestUrl":"/m/hq/s/ANIK/wiki","defaultTab":"wiki","newsList":[{"id":"1103525572","title":"TELA Bio董事会高层变动:主席道格·埃文斯及三名董事库尔特·阿扎巴津、文斯·伯吉斯、费德里卡·奥布莱恩将离任","url":"https://stock-news.laohu8.com/highlight/detail?id=1103525572","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103525572?lang=zh_cn&edition=full","pubTime":"2026-05-01 04:45","pubTimestamp":1777581942,"startTime":"0","endTime":"0","summary":"医疗技术公司TELA Bio, Inc.宣布其董事会将迎来重大人事调整。公司现任董事会主席道格·埃文斯已决定辞去主席及董事职务。与此同时,库尔特·阿扎巴津、文斯·伯吉斯以及费德里卡·奥布莱恩三位董事也将一同离开董事会。\n此次多位核心董事的集中离任,标志着TELA Bio公司治理结构进入一个关键过渡期。公司未来的战略方向与领导层构成备受市场关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BVS","ELUT","BK4139","ANIK","TELA","AXGN","BK4198","MDXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110396189","title":"TELA Bio宣布董事会战略革新:引入四位资深商业领袖加速增长并推动盈利进程,同时公布2026年第一季度初步营收数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1110396189","media":"美股速递","labels":["executive","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110396189?lang=zh_cn&edition=full","pubTime":"2026-05-01 04:44","pubTimestamp":1777581859,"startTime":"0","endTime":"0","summary":"TELA Bio公司今日宣布对其董事会进行战略性革新,新引入四位拥有丰富行业经验的商业领袖。这一举措旨在加速公司业务增长,并推动实现盈利目标的战略路径。与此同时,该公司同步披露了2026年第一季度的初步营收业绩。此次董事会成员调整凸显了TELA Bio强化商业运营能力的决心。在公布董事会变动之际,TELA Bio还提前释放了2026年第一季度的营收信号。董事会焕新与营收数据公布的双重消息,标志着TELA Bio正积极推动企业发展的新阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AXGN","BVS","BK4198","ELUT","BK4139","BK4082","MDXG","TELA","ANIK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178991628","title":"阿尼卡医疗:Cingal与Hyalofast仍为2026年核心战略重点 积极筹备未来美国市场上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1178991628","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178991628?lang=zh_cn&edition=full","pubTime":"2026-02-26 20:09","pubTimestamp":1772107740,"startTime":"0","endTime":"0","summary":"阿尼卡医疗公司近日明确表示,其创新产品Cingal与Hyalofast将继续作为公司至2026年的核心战略发展重点。当前,公司正全力推进这两款产品未来在美国市场的上市筹备工作,旨在通过强化产品管线布局,为长期增长奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608845560","title":"阿尼卡疗法盘中异动 下午盘大幅拉升5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608845560","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608845560?lang=zh_cn&edition=full","pubTime":"2026-02-03 04:00","pubTimestamp":1770062452,"startTime":"0","endTime":"0","summary":"北京时间2026年02月03日04时00分,阿尼卡疗法股票出现异动,股价快速上涨5.20%。截至发稿,该股报9.71美元/股,成交量11.299万股,换手率0.78%,振幅5.36%。机构评级方面,在所有2家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。阿尼卡疗法股票所在的制药行业中,整体涨幅为0.57%。阿尼卡疗法公司简介:Anika Therapeutics Inc 是一家骨科药物公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020304005297a48aca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020304005297a48aca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANIK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197353778","title":"阿尼卡医疗第三季度收入为2781.7万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1197353778","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197353778?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:41","pubTimestamp":1763570484,"startTime":"0","endTime":"0","summary":"11月5日(路透社)- 阿尼卡医疗第三季度税前亏损为223.6万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANIK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505279048","title":"阿尼卡疗法盘中异动 早盘大幅拉升5.78%报17.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505279048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505279048?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:37","pubTimestamp":1737470223,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时37分,阿尼卡疗法股票出现异动,股价快速上涨5.78%。截至发稿,该股报17.00美元/股,成交量668股,换手率0.00%,振幅0.00%。机构评级方面,在所有2家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。阿尼卡疗法股票所在的制药行业中,整体涨幅为0.81%。阿尼卡疗法公司简介:Anika Therapeutics Inc 是一家骨科药物公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223703960bba45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223703960bba45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANIK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504716411","title":"阿尼卡疗法盘中异动 股价大涨6.33%报17.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504716411","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504716411?lang=zh_cn&edition=full","pubTime":"2025-01-17 22:37","pubTimestamp":1737124677,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日22时37分,阿尼卡疗法股票出现波动,股价急速拉升6.33%。截至发稿,该股报17.22美元/股,成交量2748股,换手率0.02%,振幅0.00%。机构评级方面,在所有2家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。阿尼卡疗法股票所在的制药行业中,整体跌幅为0.68%。阿尼卡疗法公司简介:Anika Therapeutics Inc 是一家骨科药物公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501172237589607991b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501172237589607991b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANIK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2482342292","title":"阿尼卡疗法2024财年第三财季实现净利润-29.92百万美元,同比减少354.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482342292","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482342292?lang=zh_cn&edition=full","pubTime":"2024-11-10 00:00","pubTimestamp":1731168041,"startTime":"0","endTime":"0","summary":"11月10日,阿尼卡疗法公布财报,公告显示公司2024财年第三财季净利润为-29.92百万美元,同比减少354.71%;其中营业收入为38.75百万美元,同比减少6.56%,每股基本收益为-2.03美元。从资产负债表来看,阿尼卡疗法总负债51.54百万美元,其中短期债务2.29百万美元,资产负债比为0.05,流动比率为0.06。机构评级:截至2024年11月10日,当前有2家机构对阿尼卡疗法目标价做出预测,其中目标均价为26.50美元,其中最低目标价为25.00美元,最高目标价为28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000100abb0ff83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000100abb0ff83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANIK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2481938574","title":"阿尼卡疗法盘中异动 股价大涨5.28%报17.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481938574","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481938574?lang=zh_cn&edition=full","pubTime":"2024-11-07 00:38","pubTimestamp":1730911108,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日00时38分,阿尼卡疗法股票出现波动,股价快速上涨5.28%。截至发稿,该股报17.16美元/股,成交量4.8324万股,换手率0.33%,振幅4.29%。阿尼卡疗法股票所在的制药行业中,整体跌幅为1.90%。其相关个股中,Sunshine Biopharma Inc C/Wts 、Scilex Holding Company C/Wts 10/11/2027 、Siga Technologies Inc.涨幅较大,Canopy Growth Corporation、Sunshine Biopharma Inc.、Biofrontera Inc.较为活跃,换手率分别为10.83%、9.57%、8.09%,振幅较大的相关个股有Gelteq Limited、脑再生科技、极光大麻,振幅分别为20.88%、17.61%、16.95%。阿尼卡疗法公司简介:Anika Therapeutics Inc 是一家骨科药物公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110700382898e40f2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110700382898e40f2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANIK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2481556509","title":"阿尼卡疗法盘中异动 股价大涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481556509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481556509?lang=zh_cn&edition=full","pubTime":"2024-11-05 03:52","pubTimestamp":1730749977,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日03时52分,阿尼卡疗法股票出现异动,股价急速上涨5.14%。截至发稿,该股报17.38美元/股,成交量14.7559万股,换手率1.00%,振幅7.38%。机构评级方面,在所有2家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。阿尼卡疗法股票所在的制药行业中,整体跌幅为0.96%。阿尼卡疗法公司简介:Anika Therapeutics Inc 是一家骨科药物公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105035257971a43ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105035257971a43ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BFRI","ANIK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2479809090","title":"阿尼卡疗法盘中异动 股价大跌13.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479809090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479809090?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:33","pubTimestamp":1730381589,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时33分,阿尼卡疗法股票出现异动,股价快速下挫13.37%。截至发稿,该股报21.38美元/股,成交量1016股,换手率0.01%,振幅0.00%。阿尼卡疗法股票所在的制药行业中,整体跌幅为0.85%。其相关个股中,Avadel Pharmaceuticals Plc、Gelteq Limited、Bausch Health Companies Inc.涨幅较大,Mira Pharmaceuticals, Inc.、Shuttle Pharmaceuticals Holdings, Inc.、Avadel Pharmaceuticals Plc较为活跃,换手率分别为4.74%、1.67%、0.99%,振幅较大的相关个股有阿尼卡疗法、Gelteq Limited、Mira Pharmaceuticals, Inc.,振幅分别为11.10%、9.28%、7.73%。阿尼卡疗法公司简介:Anika Therapeutics Inc 是一家骨科药物公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031213309ab8b8343&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031213309ab8b8343&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GELS","BK4139","ANIK"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.anika.com","stockEarnings":[{"period":"1week","weight":-0.082},{"period":"1month","weight":-0.0169},{"period":"3month","weight":0.4521},{"period":"6month","weight":0.4772},{"period":"1year","weight":-0.0202},{"period":"ytd","weight":0.514}],"compareEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.0948},{"period":"3month","weight":0.0413},{"period":"6month","weight":0.0597},{"period":"1year","weight":0.2669},{"period":"ytd","weight":0.0529}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Anika Therapeutics, Inc.成立于1992年。该公司是骨关节炎疼痛管理和再生解决方案领域的全球领导者,专注于早期骨科干预。公司利用其专有的透明质酸(“HA”)技术开发差异化产品。在与医生建立牢固合作关系的推动下,Anika致力于开拓基于HA的创新技术,重新定义骨科护理。","yearOnYearQuotes":[{"month":1,"riseRate":0.515152,"avgChangeRate":0.022644},{"month":2,"riseRate":0.575758,"avgChangeRate":0.075802},{"month":3,"riseRate":0.484848,"avgChangeRate":-0.011233},{"month":4,"riseRate":0.545455,"avgChangeRate":0.045647},{"month":5,"riseRate":0.575758,"avgChangeRate":0.015657},{"month":6,"riseRate":0.424242,"avgChangeRate":0.021001},{"month":7,"riseRate":0.454545,"avgChangeRate":0.025173},{"month":8,"riseRate":0.515152,"avgChangeRate":0.015678},{"month":9,"riseRate":0.484848,"avgChangeRate":-0.003886},{"month":10,"riseRate":0.484848,"avgChangeRate":-0.018221},{"month":11,"riseRate":0.484848,"avgChangeRate":-0.011973},{"month":12,"riseRate":0.484848,"avgChangeRate":0.039212}],"exchange":"NASDAQ","name":"阿尼卡医疗","nameEN":"Anika Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"阿尼卡医疗(ANIK)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供阿尼卡医疗(ANIK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"阿尼卡医疗,ANIK,阿尼卡医疗股票,阿尼卡医疗股票老虎,阿尼卡医疗股票老虎国际,阿尼卡医疗行情,阿尼卡医疗股票行情,阿尼卡医疗股价,阿尼卡医疗股市,阿尼卡医疗股票价格,阿尼卡医疗股票交易,阿尼卡医疗股票购买,阿尼卡医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"阿尼卡医疗(ANIK)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供阿尼卡医疗(ANIK)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}